HomeINAB • NASDAQ
IN8bio Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.66M | -34.53% |
Net income | -5.55M | 35.18% |
Net profit margin | — | — |
Earnings per share | -2.10 | 65.00% |
EBITDA | -5.16M | 37.04% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.89M | -8.66% |
Total assets | 19.87M | -22.23% |
Total liabilities | 5.99M | -25.31% |
Total equity | 13.88M | — |
Shares outstanding | 3.03M | — |
Price to book | 0.42 | — |
Return on assets | -69.34% | — |
Return on capital | -75.15% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -5.55M | 35.18% |
Cash from operations | -3.12M | 60.58% |
Cash from investing | — | — |
Cash from financing | 3.89M | 1,505.42% |
Net change in cash | 771.00K | 109.33% |
Free cash flow | -1.13M | 75.22% |
Previous close
$2.14
Day range
$2.06 - $2.22
Year range
$2.06 - $30.60
Market cap
7.34M USD
Avg Volume
299.58K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2016
Website
Employees
18
